Obviousness Under 35 U.S.C. 103 in the United States

IBC's Biotech and Pharmaceutical Patenting Conference
January 27, 2009

Partner Bruce C. Haas spoke at IBC’s Biotech and Pharmaceutical Patenting Conference on January 27th in Munich. His presentation was entitled “Obviousness Under 35 U.S.C. §103 in the United States.”

View Attachment (PDF)